AC T08464
XX
ID T08464
XX
DT 23.01.2006 (created); jag.
DT 15.04.2016 (updated); hna.
CO Copyright (C), QIAGEN.
XX
FA C/EBPalpha
XX
SY BPc; C/EBP; C/EBP alpha; C/EBPalpha; C/EBPalpha(p42); CBP; CCAAT Enhancer Binding Protein alpha; CCAAT/enhancer binding protein alpha; CEBPA; EBP20; p42(C/EBPalpha); p42C/EBPalpha.
XX
OS mouse, Mus musculus
OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; rodentia; myomorpha; muridae; murinae
XX
GE G000490 Cebpa.
XX
CL C0008; bZIP; 1.1.8.1.1.
XX
FF The affinity of C/EBPalpha binding to Nupr1 G042247 promoter is higher than C/EBPbeta [5];
XX
IN T08464 C/EBPalpha; mouse, Mus musculus.
IN T04203 FOXO1A; mouse, Mus musculus.
IN T01302 GATA-2; mouse, Mus musculus.
IN T16993 MIBP1; mouse, Mus musculus.
IN T08563 NF-YA; Mammalia.
IN T22189 RECC1; mouse, Mus musculus.
IN T10505 TTF-1; Mammalia.
XX
MX M00116 V$CEBPA_01.
MX M07412 V$CEBPA_04.
MX M07037 V$CEBPA_Q4.
MX M01866 V$CEBPA_Q6.
MX M00159 V$CEBP_01.
MX M00201 V$CEBP_C.
MX M00190 V$CEBP_Q2.
MX M00912 V$CEBP_Q2_01.
MX M00770 V$CEBP_Q3.
MX M00249 V$CHOP_01.
XX
BS R39946.
BS R57365.
BS R57366.
BS R32278.
BS R36013.
BS R38277.
BS R20520.
BS R29866.
BS R29867.
BS R29868.
BS R23180.
BS R37773.
BS R20524.
BS R31971.
BS R39907.
BS R39908.
BS R42260.
BS R42264.
BS R32324.
BS R60521.
BS R20625.
BS R41835.
BS R03135.
BS R28460.
BS R28369.
BS R28370.
BS R61577.
BS R37804.
BS R37806.
BS R62515.
BS R73123.
BS R64373.
BS R33469.
BS R62523.
BS R62525.
BS R37049.
BS R67676.
BS R67677.
BS R23524.
BS R36284.
BS R26887.
BS R20515.
BS R26872.
BS R21754.
BS R66204.
BS R29474.
BS R62741.
BS R62742.
BS R67929.
BS R67930.
BS R33702.
BS R33703.
BS R33709.
BS R33705.
BS R23087.
BS R64700.
BS R63925.
BS R66205.
BS R66209.
BS R39451.
BS R64245.
BS R72787.
BS R72788.
BS R67816.
BS R60860.
BS R21609.
BS R00097.
BS R34581.
XX
DR TRANSPATH: MO000058349.
DR TRANSCOMPEL: C00456.
DR TRANSCOMPEL: C00585.
DR UniProtKB: P53566;
XX
RN [1]; RE0025710.
RX PUBMED: 11867521.
RA Wang H., Goode T., Iakova P., Albrecht J. H., Timchenko N. A.
RT C/EBPalpha triggers proteasome-dependent degradation of cdk4 during growth arrest.
RL EMBO J. 21:930-41 (2002).
RN [2]; RE0032033.
RX PUBMED: 12757710.
RA Iakova P., Awad S. S., Timchenko N. A.
RT Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest.
RL Cell 113:495-506 (2003).
RN [3]; RE0035887.
RX PUBMED: 14701740.
RA Ross S. E., Radomska H. S., Wu B., Zhang P., Winnay J. N., Bajnok L., Wright W. S., Schaufele F., Tenen D. G., MacDougald O. A.
RT Phosphorylation of C/EBPalpha inhibits granulopoiesis.
RL Mol. Cell. Biol. 24:675-686 (2004).
RN [4]; RE0036169.
RX PUBMED: 15632071.
RA Tong Q., Tsai J., Tan G., Dalgin G., Hotamisligil G. S.
RT Interaction between GATA and the C/EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation.
RL Mol. Cell. Biol. 25:706-715 (2005).
RN [5]; RE0041442.
RX PUBMED: 10510303.
RA Vasseur S., Mallo G. V., Garcia-Montero A., Ortiz E. M., Fiedler F., Canepa E., Moreno S., Iovanna J. L.
RT Structural and functional characterization of the mouse p8 gene: promotion of transcription by the CAAT-enhancer binding protein alpha (C/EBPalpha) and C/EBPbeta trans-acting factors involves a C/EBP cis-acting element and other regions of the promoter
RL Biochem. J. 343:377-83 (1999).
RN [6]; RE0042688.
RX PUBMED: 11684017.
RA Wang H., Iakova P., Wilde M., Welm A., Goode T., Roesler W. J., Timchenko N. A.
RT C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4
RL Mol. Cell 8:817-28 (2001).
RN [7]; RE0047660.
RX PUBMED: 12727880.
RA Wiper-Bergeron N., Wu D., Pope L., Schild-Poulter C., Hache R. J.
RT Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex.
RL EMBO J. 22:2135-2145 (2003).
RN [8]; RE0048262.
RX PUBMED: 16210377.
RA Singh R., Artaza J. N., Taylor W. E., Braga M., Yuan X., Gonzalez-Cadavid N. F., Bhasin S.
RT Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors.
RL Endocrinology 147:141-154 (2006).
RN [9]; RE0048349.
RX PUBMED: 11356826.
RA Hong S., Park S. J., Kong H. J., Shuman J. D., Cheong J.
RT Functional interaction of bZIP proteins and the large subunit of replication factor C in liver and adipose cells.
RL J. Biol. Chem. 276:28098-28105 (2001).
RN [10]; RE0048488.
RX PUBMED: 15691842.
RA Yu C., Markan K., Temple K. A., Deplewski D., Brady M. J., Cohen R. N.
RT The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis.
RL J. Biol. Chem. 280:13600-13605 (2005).
RN [11]; RE0048515.
RX PUBMED: 16644732.
RA McFie P. J., Wang G. L., Timchenko N. A., Wilson H. L., Hu X., Roesler W. J.
RT Identification of a co-repressor that inhibits the transcriptional and growth-arrest activities of CCAAT/enhancer-binding protein alpha.
RL J. Biol. Chem. 281:18069-18080 (2006).
RN [12]; RE0048532.
RX PUBMED: 16595692.
RA Xu Y., Zhou Y. L., Luo W., Zhu Q. S., Levy D., MacDougald O. A., Snead M. l.
RT NF-Y and CCAAT/enhancer-binding protein alpha synergistically activate the mouse amelogenin gene.
RL J. Biol. Chem. 281:16090-16098 (2006).
RN [13]; RE0050196.
RX PUBMED: 15987634.
RA Bouaboula M., Hilairet S., Marchand J., Fajas L., Le Fur G., Casellas P.
RT Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation.
RL Eur. J. Pharmacol. 517:174-181 (2005).
RN [14]; RE0053554.
RX PUBMED: 16807249.
RA Qiao L., MacDougald O. A., Shao J.
RT CCAAT/enhancer-binding protein alpha mediates induction of hepatic phosphoenolpyruvate carboxykinase by p38 mitogen-activated protein kinase.
RL J. Biol. Chem. 281:24390-24397 (2006).
RN [15]; RE0065384.
RX PUBMED: 15930175.
RA Hogan J. C., Stephens J. M.
RT Effects of leukemia inhibitory factor on 3T3-L1 adipocytes.
RL J. Endocrinol. 185:485-496 (2005).
XX
//